Published July 9, 2012 | Version v1
Journal article Open

Cooperative Interaction between the MUC1-C Oncoprotein and the Rab31 GTPase in Estrogen Receptor-Positive Breast Cancer Cells

  • 1. Harvard University
  • 2. University of Chicago
  • 3. Dana-Farber Cancer Institute

Description

Rab31 is a member of the Ras superfamily of small GTPases that has been linked to poor outcomes in patients with breast cancer. The MUC1-C oncoprotein is aberrantly overexpressed in most human breast cancers and also confers a poor prognosis. The present results demonstrate that MUC1-C induces Rab31 expression in estrogen receptor positive (ER+) breast cancer cells. We show that MUC1-C forms a complex with estrogen receptor α (ERα) on the Rab31 promoter and activates Rab31 gene transcription in an estrogen-dependent manner. In turn, Rab31 contributes to the upregulation of MUC1-C abundance in breast cancer cells by attenuating degradation of MUC1-C in lysosomes. Expression of an inactive Rab31(S20N) mutant in nonmalignant breast epithelial cells confirmed that Rab31 regulates MUC1-C expression. The functional significance of the MUC1-C/Rab31 interaction is supported by the demonstration that Rab31 confers the formation of mammospheres by a MUC1-C-dependent mechanism. Analysis of microarray databases further showed that (i) Rab31 is expressed at higher levels in breast cancers as compared to that in normal breast tissues, (ii) MUC1+ and ER+ breast cancers have increased levels of Rab31 expression, and (iii) patients with Rab31-positive breast tumors have a significantly decreased ten-year overall survival as compared to those with Rab31-negative tumors. These findings indicate that MUC1-C and Rab31 function in an autoinductive loop that contributes to overexpression of MUC1-C in breast cancer cells.

Files

journal.pone.0039432.pdf

Files (1.1 MB)

Name Size Download all
Article
md5:8e07119d9419ba33f22da0d486dbf9db
1.1 MB Preview Download
md5:7cbadd199ba9d8bc8cb8b4ed42fabf83
11.0 kB Preview Download

Additional details

Identifiers

DOI
10.1371/journal.pone.0039432
Other
oai:uchicago.tind.io:10399

Funding

National Cancer Institute
CA97098
National Cancer Institute
CA42802
National Cancer Institute
CA100707

UChicago Information

Division(s)
Biological Sciences Division
Department(s)
Radiation and Cellular Oncology